XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy

XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy

XIAOPI formula is a national approved drug prescribed to patients with high breast cancer risk. Previously we demonstrated that XIAOPI formula could inhibit breast cancer metastasis via suppressing CXCL1 expression, and postulated that “autophagy in cancer” might be one of its most core anti-cancer...

Full description

Bibliographic Details
Main Authors: Neng Wang, Bowen Yang, Gulizeba Muhetaer, Shengqi Wang, Yifeng Zheng, Jiahong Lu, Min Li, Fengxue Zhang, Honglin Situ, Yi Lin, Zhiyu Wang
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Breast cancer chemosensitivity
Autophagy
CXCL1/HMGB1 axis
XIAOPI formula
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332219334730

Internet

http://www.sciencedirect.com/science/article/pii/S0753332219334730

Similar Items